5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomized study
Bonneterre, J.; Hecquet, B.
European Journal of Cancer 30a(7): 1041-1042
1994
ISSN/ISBN: 0959-8049 PMID: 7946571 Document Number: 424272
Document emailed within 1 workday
Related Documents
Hesketh, P. 1995: Prophylaxis with oral granisetron for acute emesis induced by moderately emetogenic chemotherapy Seminars in Oncology 22(4 Suppl 10): 19-23Raynov, J.; Danon, S.; Valerianova, Z. 2002: Control of acute emesis in repeated courses of moderately emetogenic chemotherapy Journal of BUON: Official Journal of the Balkan Union of Oncology 7(1): 57-60
Anastasia, P.J. 2000: Effectiveness of oral 5-HT3 receptor antagonists for emetogenic chemotherapy Oncology Nursing Forum 27(3): 483-493
Smith, I.E. 1990: A comparison of two dose levels of granisetron in patients receiving moderately emetogenic cytostatic chemotherapy. the Granisetron Study Group European Journal of Cancer 26(Suppl 1): S19-S23
Hesketh, P.J.; Crews, J.R.; Cohen, R.; Blackburn, L.M.; Friedman, C.J. 2000: Antiemetic efficacy of single-dose oral granisetron (1 mg vs 2 mg) with moderately emetogenic chemotherapy Cancer Journal 6(3): 157-161
Chiou, T.J.; Tzeng, W.F.; Wang, W.S.; Yen, C.C.; Fan, F.S.; Liu, J.H.; Chen, P.M. 2000: Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy Zhonghua Yi Xue Za Zhi 63(10): 729-736
Chang, C.S.; Chen, L.T.; Huang, S.M.; Liu, T.C.; Lin, S.F.; Chen, T.P.; Wei, T.C. 1997: Comparison of intravenous granisetron with metoclopramide plus dexamethasone in the prevention of nausea and vomiting associated with emetogenic cytotoxic chemotherapy Kaohsiung Journal of Medical Sciences 13(2): 97-102
Burris, H.; Hesketh, P.; Cohn, J.; Moriconi, W.; Ryan, T.; Friedman, C.; Fitts, D. 1996: Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy Cancer Journal from Scientific American 2(2): 85-90
Perez, E.A.; Lembersky, B.; Kaywin, P.; Kalman, L.; Yocom, K.; Friedman, C. 1998: Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy Cancer Journal from Scientific American 4(1): 52-58
Okamoto, S.; Takahashi, S.; Tanosaki, R.; Sakamaki, H.; Onozawa, Y.; Oh, H.; Miyawaki, S.; Kimura, Y.; Toyama, K.; Ikeda, Y.; Asano, S. 1996: Granisetron in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study Bone Marrow Transplantation 17(5): 679-683
Taguchi, K.; Iihara, H.; Ishihara, M.; Komori, Y.; Tanizawa, K.; Matsuura, K.; Itoh, Y. 2009: Comparison of antiemetic efficacy between single and repeated treatments with a 5-HT3 receptor antagonist in breast cancer patients with high-risk emetogenic chemotherapy Anticancer Research 29(5): 1721-1725
Lehoczky, O. 1998: Report on the antiemetic effectivity of a single 1 mg oral granisetron in moderately emetogenic chemotherapies of gynecological malignancies European Journal of Gynaecological Oncology 19(5): 449-452
Takatsuki, K.; Kado, T.; Satouchi, M.; Nakajima, T.; Nagai, K.; Ohsugi, F.; Yanagida, E.; Minegaki, A. 1998: Psychiatric studies of chemotherapy and chemotherapy-induced nausea and vomiting of patients with lung or thymic cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(3): 403-408
Feng, F.; Zhang, P.; He, Y.; Li, Y.; Zhou, M.; Chen, G.; Li, L. 2002: Clinical comparison of the selective serotonin3 antagonists ramosetron and granisetron in treating acute chemotherapy-induced emesis, nausea and anorexia Chinese Medical Sciences Journal 17(3): 168-172
Breau, J.L.; Israel, L.; Pochmalicki, G.; Spaulding, C. 1983: Efficacy of methylprednisolone in the prevention of vomiting due to chemotherapy with platinum salts in a randomized trial Presse Medicale 12(33): 2058
Palop, D.; Romero, A.; Villamayor, F.; Conejo, L.; Sacristán, A.; Ortiz, J.A. 1997: Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists Arzneimittel-Forschung 47(4a): 450-454
Cavanagh, R.L.; Buyniski, J.P.; Schwartz, S.E. 1987: Prevention of aspirin-induced gastric mucosal injury by histamine H2 receptor antagonists: a crossover endoscopic and intragastric pH study in the dog Journal of Pharmacology and Experimental Therapeutics 243(3): 1179-1184
Ivarsson, L.E. 1984: Antacids and H2-receptor antagonists in the prophylaxis and treatment of erosive gastritis: clinical aspects Scandinavian Journal of Gastroenterology. Suppl 105: 86-91
Scotté, F.; Chastenet, M.; Leroy, P.; Aumont, L.; Goudiaby, C.él.; Legeay, K.; Beuzeboc, P. 2019: Nausea and vomiting induced by chemotherapy La Revue du Praticien 69(1): 49-54
Kurita, A.; Takashima, S.; Nakata, M.; Kubo, Y.; Saiki, T.; Ohsumi, S.; Yokoyama, N.; Tanada, M.; Takiyama, W.; Saeki, H. 1997: Granisetron versus granisetron plus methylprednisolone in the prevention of chemotherapy induced nausea and vomiting--in adjuvant chemotherapy, including CDDP against gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(1): 49-54